SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    William D Graf, Geoffrey Miller, Saskia K Nagel, Addressing the problem of ADHD medication as neuroenhancements, Expert Review of Neurotherapeutics, 2014, 14, 5, 569

    CrossRef

  2. 2
    Kevin B. Freeman, Brian C. McMaster, Peter G. Roma, William L. Woolverton, Assessment of the effects of contingent histamine injections on the reinforcing effectiveness of cocaine using behavioral economic and progressive-ratio designs, Psychopharmacology, 2014, 231, 12, 2395

    CrossRef

  3. 3
    Emma Dyken, Foon Yin Lai, Phong K. Thai, Christoph Ort, Raimondo Bruno, Wayne Hall, K. Paul Kirkbride, Jochen F. Mueller, Jeremy Prichard, Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility, Drug and Alcohol Review, 2014, 33, 5
  4. 4
    Nicole A. Crowley, Patrick A. Cody, Margaret I. Davis, David M. Lovinger, Yolanda Mateo, Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol, European Journal of Neuroscience, 2014, 39, 4
  5. 5
    Sharlene Kaye, Shane Darke, Michelle Torok, Diversion and misuse of pharmaceutical stimulants among illicit drug users, Addiction Research & Theory, 2014, 22, 2, 109

    CrossRef

  6. 6
    Samantha J. Lookatch, Todd M. Moore, Elizabeth C. Katz, Effects of Gender and Motivations on Perceptions of Nonmedical Use of Prescription Stimulants, Journal of American College Health, 2014, 62, 4, 255

    CrossRef

  7. 7
    Laura Y. Cabrera, Nicholas S. Fitz, Peter B. Reiner, Empirical Support for the Moral Salience of the Therapy-Enhancement Distinction in the Debate Over Cognitive, Affective and Social Enhancement, Neuroethics, 2014,

    CrossRef

  8. 8
    Willy Pedersen, From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder, Addiction Research & Theory, 2014, 1

    CrossRef

  9. 9
    Li-Tzy Wu, Marvin S. Swartz, Kathleen T. Brady, Dan G. Blazer, Rick H. Hoyle, Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12–34 years in the United States, Journal of Psychiatric Research, 2014, 59, 189

    CrossRef

  10. 10
    David R. Moore, Daniel A. Burgard, Ramsey G. Larson, Mikael Ferm, Psychostimulant use among college students during periods of high and low stress: An interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data, Addictive Behaviors, 2014, 39, 5, 987

    CrossRef

  11. 11
    V. L. Shammas, S. Sandberg, W. Pedersen, Trajectories to Mid- and Higher-level Drug Crimes: Penal Misrepresentations of Drug Dealers in Norway, British Journal of Criminology, 2014, 54, 4, 592

    CrossRef

  12. 12
    Alexander M. Ponizovsky, Eli Marom, Israel Fitoussi, Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005–2012, Pharmacoepidemiology and Drug Safety, 2014, 23, 5
  13. 13
    Stéphane Deline, Stéphanie Baggio, Joseph Studer, Alexandra N'Goran, Marc Dupuis, Yves Henchoz, Meichun Mohler-Kuo, Jean-Bernard Daeppen, Gerhard Gmel, Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland, International Journal of Environmental Research and Public Health, 2014, 11, 3, 3032

    CrossRef

  14. 14
    Daniel A. Burgard, Caleb Banta-Green, Jennifer A. Field, Working Upstream: How Far Can You Go with Sewage-Based Drug Epidemiology?, Environmental Science & Technology, 2014, 48, 3, 1362

    CrossRef

  15. 15
    Michael B. Lensing, Pål Zeiner, Leiv Sandvik, Stein Opjordsmoen, Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians, ADHD Attention Deficit and Hyperactivity Disorders, 2013, 5, 4, 369

    CrossRef

  16. 16
    Tim K Mackey, Bryan A Liang, Steffanie A Strathdee, Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform, Journal of Medical Internet Research, 2013, 15, 7, e143

    CrossRef

  17. 17
    Ilina Singh, Angela M. Filipe, Imre Bard, Meredith Bergey, Lauren Baker, Globalization and Cognitive Enhancement: Emerging Social and Ethical Challenges for ADHD Clinicians, Current Psychiatry Reports, 2013, 15, 9

    CrossRef

  18. 18
    Mats Fredriksen, Anne Halmøy, Stephen V. Faraone, Jan Haavik, Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies, European Neuropsychopharmacology, 2013, 23, 6, 508

    CrossRef

  19. 19
    Elisabeth Frauger, Christophe Moracchini, Reynald Boisselier, David Braunstein, Xavier Thirion, Joëlle Micallef, OPPIDUM surveillance program: 20 years of information on drug abuse in France, Fundamental & Clinical Pharmacology, 2013, 27, 6
  20. 20
    Seo Young Yoon, Ike dela Peña, Sung Mok Kim, Tae Sun Woo, Chan Young Shin, Kun Ho Son, Haeil Park, Yong Soo Lee, Jong Hoon Ryu, Mingli Jin, Kyeong-Man Kim, Jae Hoon Cheong, Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro, Archives of Pharmacal Research, 2013, 36, 1, 134

    CrossRef

  21. 21
    Daniel A. Burgard, Rick Fuller, Brian Becker, Rebecca Ferrell, M.J. Dinglasan-Panlilio, Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: Wastewater analysis of amphetamine and ritalinic acid, Science of The Total Environment, 2013, 450-451, 242

    CrossRef

  22. 22
    Barbara Piskorska, Barbara Miziak, Stanisław J Czuczwar, Kinga K Borowicz, Safety issues around misuse of antiepileptics, Expert Opinion on Drug Safety, 2013, 12, 5, 647

    CrossRef

  23. 23
    Emma Whelan, Mark Asbridge, The OxyContin crisis: Problematisation and responsibilisation strategies in addiction, pain, and general medicine journals, International Journal of Drug Policy, 2013, 24, 5, 402

    CrossRef

  24. 24
    Aribert Rothenberger, Lillian Geza Rothenberger, Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations, Current Treatment Options in Neurology, 2012, 14, 6, 594

    CrossRef